{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:14:09Z","timestamp":1760026449979,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.ajem.2021.05.040","type":"journal-article","created":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T12:46:32Z","timestamp":1621601192000},"page":"24-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Risk factors and predictors of QTc prolongation in critically ill Chinese patients"],"prefix":"10.1016","volume":"49","author":[{"given":"Zhidong","family":"Qi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sibo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingdong","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuyuan","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junbo","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huaiquan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ajem.2021.05.040_bb0005","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jacc.2010.01.001","volume":"55","author":"Drew","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ajem.2021.05.040_bb0010","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1365-2125.2010.03660.x","article-title":"Drug- and non-drug-associated QT interval prolongation","volume":"70","author":"Van Noord","year":"2010","journal-title":"Br J Clin Pharmacol"},{"issue":"10","key":"10.1016\/j.ajem.2021.05.040_bb0015","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1056\/NEJMra032426","article-title":"Drug-induced prolongation of the QT interval","volume":"350","author":"Roden","year":"2004","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.ajem.2021.05.040_bb0020","first-page":"961","article-title":"Task force recommendations for prevention and treatment of acquired long QT syndrome","volume":"38","author":"Arrhythmic Working Group of Chinese Society of Cardiology of Chinese Medical Association","year":"2010","journal-title":"Chin J Cardiol"},{"issue":"3","key":"10.1016\/j.ajem.2021.05.040_bb0025","first-page":"294","article-title":"Research Progress in risk stratification of long-QT syndrome","volume":"33","author":"Zhao","year":"2012","journal-title":"Adv Cardiovasc Dis"},{"issue":"5","key":"10.1016\/j.ajem.2021.05.040_bb0030","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jcrc.2014.05.005","article-title":"Corrected QT-interval prolongation and variability in intensive care patients","volume":"29","author":"Hoogstraaten","year":"2014","journal-title":"J Crit Care"},{"issue":"1","key":"10.1016\/j.ajem.2021.05.040_bb0035","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/0897190009356549","article-title":"Drug-induced QTc-interval prolongation in the intensive care unit: incidence and predictors","volume":"23","author":"Ng","year":"2010","journal-title":"J Pharm Pract"},{"issue":"6","key":"10.1016\/j.ajem.2021.05.040_bb0040","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jelectrocard.2010.05.016","article-title":"How many patients need QT interval monitoring in critical care units? Preliminary report of the QT in Practice study","volume":"43","author":"Pickham","year":"2010","journal-title":"J Electrocardiol"},{"key":"10.1016\/j.ajem.2021.05.040_bb0045","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jcrc.2019.09.014","article-title":"The incidence, predictors and outcomes of QTc prolongation in critically ill patients","volume":"54","author":"Russell","year":"2018","journal-title":"J Crit Care"},{"issue":"8","key":"10.1016\/j.ajem.2021.05.040_bb0050","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/CIRCULATIONAHA.109.192704","article-title":"Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation","volume":"121","author":"Drew","year":"2010","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ajem.2021.05.040_bb0055","doi-asserted-by":"crossref","first-page":"32","DOI":"10.4037\/ccn2012900","article-title":"Acquired long QT syndrome: frequency, onset, and risk factors in intensive care patients","volume":"32","author":"Kozik","year":"2012","journal-title":"Crit Care Nurse"},{"issue":"2","key":"10.1016\/j.ajem.2021.05.040_bb0060","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/CCM.0b013e318232db4a","article-title":"High prevalence of corrected QT interval prolongation in acutely ill patients is associated with mortality: results of the QT in practice (QTIP) study*","volume":"40","author":"Pickham","year":"2012","journal-title":"Crit Care Med"},{"issue":"6 Pt 1","key":"10.1016\/j.ajem.2021.05.040_bb0065","first-page":"552","article-title":"Minimizing the risks associated with QTc prolongation in people with schizophrenia. A consensus statement by the cardiac safety in schizophrenia group","volume":"28","author":"Ames","year":"2002","journal-title":"L\u2019Encephale"},{"issue":"1","key":"10.1016\/j.ajem.2021.05.040_bb0070","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11096-016-0414-2","article-title":"Risk factors for QTc-prolongation: systematic review of the evidence","volume":"39","author":"Vandael","year":"2017","journal-title":"Int J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.ajem.2021.05.040_bb0075","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.hrthm.2005.02.011","article-title":"Inaccurate electrocardiographic interpretation of long QT: the majority of physicians cannot recognize a long QT when they see one","volume":"2","author":"Viskin","year":"2005","journal-title":"Heart Rhythm"},{"issue":"9","key":"10.1016\/j.ajem.2021.05.040_bb0080","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1056\/NEJM200308283490916","article-title":"Risk stratification in the long-QT syndrome","volume":"349","author":"Ellinor","year":"2003","journal-title":"N Engl J Med"},{"year":"1997","series-title":"The assessment of the potential for QT interval prolongation by non-cardiovascular medicinal products","author":"CPMP","key":"10.1016\/j.ajem.2021.05.040_bb0090"},{"issue":"5","key":"10.1016\/j.ajem.2021.05.040_bb0095","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/2042098612454283","article-title":"Drug-induced QT interval prolongation: mechanisms and clinical management","volume":"3","author":"Nachimuthu","year":"2012","journal-title":"Ther Adv Drug Saf"},{"key":"10.1016\/j.ajem.2021.05.040_bb0100","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003264","article-title":"Which QT correction formulae to use for QT monitoring?","volume":"5","author":"Vandenberk","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.ajem.2021.05.040_bb0105","first-page":"8","article-title":"The relationship between blood glucose level and QTc duration in the critically ill","volume":"11","author":"Burkett","year":"2009","journal-title":"Crit Care Resusc"},{"issue":"4","key":"10.1016\/j.ajem.2021.05.040_bb0115","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/01.md.0000085057.63483.9b","article-title":"Torsade de pointes due to noncardiac drugs: most patients have easily identifiable risk factors","volume":"82","author":"Zeltser","year":"2003","journal-title":"Medicine"},{"issue":"5","key":"10.1016\/j.ajem.2021.05.040_bb0120","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.amjcard.2007.04.020","article-title":"Risk factors and predictors of torsade de pointes ventricular tachycardia in patients with left ventricular systolic dysfunction receiving Dofetilide","volume":"100","author":"Pedersen","year":"2007","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.ajem.2021.05.040_bb0125","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1177\/0897190017711875","article-title":"Evaluation of the effects of quetiapine on QTc prolongation in critically ill patients","volume":"31","author":"Dube","year":"2018","journal-title":"J Pharm Pract"},{"issue":"7","key":"10.1016\/j.ajem.2021.05.040_bb0130","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-121-7-199410010-00009","article-title":"Amiodarone-associated proarrhythmic effects. A review with special reference to torsade de pointes tachycardia","volume":"121","author":"Hohnloser","year":"1994","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.ajem.2021.05.040_bb0135","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/j.1540-8159.2006.00424.x","article-title":"Clinical study of amiodarone-associated torsade de pointes in Chinese people","volume":"29","author":"Geng","year":"2006","journal-title":"Pacing Clin Electrophysiol"},{"issue":"1","key":"10.1016\/j.ajem.2021.05.040_bb0140","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/europace\/eut214","article-title":"Epidemiology of symptomatic drug-induced long QT syndrome and torsade de pointes in Germany","volume":"16","author":"Sarganas","year":"2014","journal-title":"Europace"},{"issue":"3","key":"10.1016\/j.ajem.2021.05.040_bb0145","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1053\/eupc.2000.0099","article-title":"Effects of intravenous amiodarone on ventricular refractoriness, intraventricular conduction, and ventricular tachycardia induction","volume":"2","author":"Kulakowski","year":"2000","journal-title":"Europace"},{"issue":"19","key":"10.1016\/j.ajem.2021.05.040_bb0150","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1161\/01.CIR.100.19.2025","article-title":"Evidence-based analysis of amiodarone efficacy and safety","volume":"100","author":"Connolly","year":"1999","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ajem.2021.05.040_bb0155","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ihj.2017.05.024","article-title":"Incidence of drug-induced torsades de pointes with intravenous amiodarone","volume":"69","author":"Shenthar","year":"2017","journal-title":"Indian Heart J"},{"issue":"1","key":"10.1016\/j.ajem.2021.05.040_bb0160","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1254\/jjp.90.28","article-title":"In vivo assessment of acceleration of motor activity associated with acetylcholine release via 5-hydroxytryptamine4 receptor in dog intestine","volume":"90","author":"Makimoto","year":"2002","journal-title":"Jpn J Pharmacol"},{"issue":"2","key":"10.1016\/j.ajem.2021.05.040_bb0165","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1536\/jhj.44.225","article-title":"Drug interaction between mosapride and erythromycin without electrocardiographic changes","volume":"44","author":"Katoh","year":"2003","journal-title":"Jpn Heart J"},{"issue":"9","key":"10.1016\/j.ajem.2021.05.040_bb0170","first-page":"565","article-title":"Analysis of one case of sick sinus syndrome-related adverse events caused by Mosapride","volume":"23","author":"Xia","year":"2014","journal-title":"Chin J Pharmacoepidemiol"},{"issue":"2","key":"10.1016\/j.ajem.2021.05.040_bb0175","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/bcp.13457","article-title":"QTc prolongation during ciprofloxacin and fluconazole combination therapy: prevalence and associated risk factors","volume":"84","author":"Berger","year":"2018","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.ajem.2021.05.040_bb0180","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s40264-016-0477-y","article-title":"Investigating the additive interaction of QT-prolonging drugs in older people using claims data","volume":"40","author":"Meid","year":"2017","journal-title":"Drug Saf"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073567572100423X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073567572100423X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T15:53:32Z","timestamp":1760025212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073567572100423X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":34,"alternative-id":["S073567572100423X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2021.05.040","relation":{},"ISSN":["0735-6757"],"issn-type":[{"type":"print","value":"0735-6757"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors and predictors of QTc prolongation in critically ill Chinese patients","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2021.05.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}